Peptonic Medical AB (publ) (“Peptonic”) is extending the partnership with Farmasiet that will bring the entire VagVital product portfolio to the Norwegian market. Farmasiet, Norway’s largest online pharmacy, is set to launch these innovative products designed to address specific needs in intimate care, encompassing diagnosis, treatment, and prevention. The introduction of VagVital products is scheduled to commence in early 2024. Vernivia is already available at Farmasiet.
By leveraging Farmasiet’s robust presence in the Norwegian market and Peptonic Medical’s scientific expertise, this extension marks a significant step in providing customers with high-quality intimate care solutions.
“I am excited to announce Peptonic Medical’s extended partnership with Farmasiet, Norway’s largest online pharmacy, as we now also introduce our comprehensive VagVital product range to the Norwegian market. Thus, this merges our scientific expertise in women’s health with Farmasiet’s expansive platform, enabling us to deliver high-quality intimate care solutions to a wider audience. We look forward to the opportunities this collaboration will unfold.” – Fanny Falkman Grinndal, Business Manager Nordics.
For further information, please contact:
Fanny Falkman Grinndal, Business Manager Nordics
Phone: +46 70-196 17 97
